Literature DB >> 23584301

A patient with lung adenocarcinoma and RET fusion treated with vandetanib.

Oliver Gautschi1, Thilo Zander, Franziska Aebersold Keller, Klaus Strobel, Astrid Hirschmann, Stefan Aebi, Joachim Diebold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23584301     DOI： 10.1097/JTO.0b013e31828a4d07

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  42 in total

Review 1.  RET fusion gene: translation to personalized lung cancer therapy.

Authors:  Takashi Kohno; Koji Tsuta; Katsuya Tsuchihara; Takashi Nakaoku; Kiyotaka Yoh; Koichi Goto
Journal:  Cancer Sci       Date:  2013-10-01       Impact factor: 6.716

Review 2.  Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.

Authors:  Takashi Kohno; Takashi Nakaoku; Koji Tsuta; Katsuya Tsuchihara; Shingo Matsumoto; Kiyotaka Yoh; Koichi Goto
Journal:  Transl Lung Cancer Res       Date:  2015-04

3.  Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors.

Authors:  Dennis Plenker; Maximilian Riedel; Johannes Brägelmann; Marcel A Dammert; Rakhee Chauhan; Phillip P Knowles; Carina Lorenz; Marina Keul; Mike Bührmann; Oliver Pagel; Verena Tischler; Andreas H Scheel; Daniel Schütte; Yanrui Song; Justina Stark; Florian Mrugalla; Yannic Alber; André Richters; Julian Engel; Frauke Leenders; Johannes M Heuckmann; Jürgen Wolf; Joachim Diebold; Georg Pall; Martin Peifer; Maarten Aerts; Kris Gevaert; René P Zahedi; Reinhard Buettner; Kevan M Shokat; Neil Q McDonald; Stefan M Kast; Oliver Gautschi; Roman K Thomas; Martin L Sos
Journal:  Sci Transl Med       Date:  2017-06-14       Impact factor: 17.956

Review 4.  Lung cancer as a paradigm for precision oncology in solid tumours.

Authors:  Simon Schallenberg; Sabine Merkelbach-Bruse; Reinhard Buettner
Journal:  Virchows Arch       Date:  2017-07-20       Impact factor: 4.064

5.  RET fusion as a novel driver of medullary thyroid carcinoma.

Authors:  Elizabeth G Grubbs; Patrick Kwok-Shing Ng; Jacquelin Bui; Naifa L Busaidy; Ken Chen; Jeffrey E Lee; Xinyan Lu; Hengyu Lu; Funda Meric-Bernstam; Gordon B Mills; Gary Palmer; Nancy D Perrier; Kenneth L Scott; Kenna R Shaw; Steven G Waguespack; Michelle D Williams; Roman Yelensky; Gilbert J Cote
Journal:  J Clin Endocrinol Metab       Date:  2014-12-29       Impact factor: 5.958

6.  Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

Authors:  Oliver Gautschi; Julie Milia; Thomas Filleron; Juergen Wolf; David P Carbone; Dwight Owen; Ross Camidge; Vignhesh Narayanan; Robert C Doebele; Benjamin Besse; Jordi Remon-Masip; Pasi A Janne; Mark M Awad; Nir Peled; Chul-Cho Byoung; Daniel D Karp; Michael Van Den Heuvel; Heather A Wakelee; Joel W Neal; Tony S K Mok; James C H Yang; Sai-Hong Ignatius Ou; Georg Pall; Patrizia Froesch; Gérard Zalcman; David R Gandara; Jonathan W Riess; Vamsidhar Velcheti; Kristin Zeidler; Joachim Diebold; Martin Früh; Sebastian Michels; Isabelle Monnet; Sanjay Popat; Rafael Rosell; Niki Karachaliou; Sacha I Rothschild; Jin-Yuan Shih; Arne Warth; Thomas Muley; Florian Cabillic; Julien Mazières; Alexander Drilon
Journal:  J Clin Oncol       Date:  2017-03-13       Impact factor: 44.544

7.  The RET fusion gene and its correlation with demographic and clinicopathological features of non-small cell lung cancer: a meta-analysis.

Authors:  Chen Lin; Shanshan Wang; Weiwei Xie; Jianhua Chang; Yu Gan
Journal:  Cancer Biol Ther       Date:  2015-05-15       Impact factor: 4.742

8.  Preclinical Modeling of KIF5B-RET Fusion Lung Adenocarcinoma.

Authors:  Qingling Huang; Valentina E Schneeberger; Noreen Luetteke; Chengliu Jin; Roha Afzal; Mikalai M Budzevich; Rikesh J Makanji; Gary V Martinez; Tao Shen; Lichao Zhao; Kar-Ming Fung; Eric B Haura; Domenico Coppola; Jie Wu
Journal:  Mol Cancer Ther       Date:  2016-08-05       Impact factor: 6.261

Review 9.  The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.

Authors:  Valentina De Falco; Francesca Carlomagno; Hong-Yu Li; Massimo Santoro
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2017-05-10       Impact factor: 4.690

10.  The addition of anti-angiogenic tyrosine kinase inhibitors to chemotherapy for patients with advanced non-small-cell lung cancers: A meta-analysis of randomized trials.

Authors:  Bob T Li; Tristan A Barnes; David L Chan; Jarushka Naidoo; Adrian Lee; Mustafa Khasraw; Gavin M Marx; Mark G Kris; Stephen J Clarke; Alexander Drilon; Charles M Rudin; Nick Pavlakis
Journal:  Lung Cancer       Date:  2016-10-17       Impact factor: 5.705
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.